NCT05956093View on ClinicalTrials.gov

68Ga-FAPI PET/CT in the Staging of High-Grade Epithelial Ovarian Cancers: A Pilot Study

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 25, 2025

Primary Completion Date

April 25, 2026

Study Completion Date

May 30, 2026

Conditions
High Grade Serous Ovarian Cancer (HGSOC)
Interventions
RADIATION

FAPI PET CT

the utilization of Gallium 68 labelled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET/CT to accurately stage high-grade epithelial ovarian cancers.

All Listed Sponsors
lead

University Health Network, Toronto

OTHER